LGC operates laboratories in 22 countries across Europe and America, as well as sites in Brazil, China and India, generating international sales of £99.1m in 2013. Founded in 1842, it works across sectors including pharmaceuticals and agricultural bioscience. LGC is owned by private-equity firm Bridgepoint Capital following a £257m buyout in 2010. Chief executive Tim Robinson, 50, was appointed in May 2013.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.